Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | AMGN | GILD | CELG | ILMN |
| Company | Morphosys Ag ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 17.97 | 309.53 | 65.18 | 108.01 | 110.33 |
| High | 18.07 | 310.75 | 65.22 | 108.59 | 112.58 |
| Low | 17.97 | 306.32 | 64.66 | 107.27 | 110.04 |
| Last | 18.00 | 310.83 | 64.78 | 108.24 | 110.95 |
| Change | +0.04 | +3.52 | -0.14 | +0.11 | +0.33 |
| % Change | +0.22% | +1.15% | -0.22% | +0.10% | +0.30% |
| Volume | 57,428 | 514,409 | 995,685 | 191,230,496 | 390,085 |
| 20-Day Average Volume | 652,162 | 2,785,230 | 7,205,611 | 16,188,930 | 1,577,885 |
| Previous Close | 17.96 | 307.31 | 64.92 | 108.13 | 110.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.91 | 279.33 | 66.12 | 108.17 | 119.87 |
| 20-Day Raw Stochastic | 87.33% | 79.74% | 13.52% | 63.25% | 10.51% |
| 20-Day Relative Strength | 58.09% | 67.00% | 32.74% | 64.69% | 35.90% |
| Weighted Alpha | +67.39 | +33.97 | -21.06 | +46.30 | -45.07 |
| Today's Opinion | 72% Buy | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 64% Buy | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 88% Buy | 40% Sell | 100% Sell | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.76% since 05/02/24 | +11.37% since 05/02/24 | -0.64% since 05/02/24 | -1.97% since 11/13/19 | -10.23% since 05/02/24 |
| Low | 17.80 on 05/03/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 108.54 on 05/08/24 |
| High | 18.07 on 05/09/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | -0.85% since 04/09/24 | +14.68% since 04/09/24 | -7.19% since 04/09/24 | +5.14% since 10/18/19 | -16.67% since 04/09/24 |
| Low | 17.04 on 04/29/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 108.54 on 05/08/24 |
| High | 18.15 on 04/25/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 110.70 on 11/13/19 | 134.85 on 04/12/24 |
| 3-Month | |||||
| %Chg | +4.99% since 02/09/24 | +6.50% since 02/09/24 | -11.89% since 02/09/24 | +13.63% since 08/20/19 | -19.25% since 02/09/24 |
| Low | 17.04 on 04/29/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 108.54 on 05/08/24 |
| High | 18.31 on 03/12/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 147.25 on 02/16/24 |
| 6-Month | |||||
| %Chg | +129.66% since 11/09/23 | +17.42% since 11/09/23 | -13.43% since 11/09/23 | +14.14% since 05/20/19 | +4.04% since 11/09/23 |
| Low | 4.18 on 11/22/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 18.31 on 03/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,705,153 | 164,851,840 | 80,830,400 | 77,035,920 | 17,621,766 |
| Shares Outstanding, K | 150,621 | 536,435 | 1,245,077 | 711,714 | 159,300 |
| Annual Sales | 257,890,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -205,350,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 29,900,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 1,076,000,000 |
| Last Quarter Net Income | -341,960,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | -126,000,000 |
| 60-Month Beta | 1.15 | 0.60 | 0.22 | 1.41 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.24 on 04/29/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.12 | 16.24 | 10.99 | 128.20 |